Stephan Linden is currently the Director of Global Market Access at CSL, where they focus on therapeutic areas including HAE and respiratory conditions. They previously served as the Director of Market Access & Pricing for Europe at CSL. Prior to this, they held various roles related to global health economics and outcomes research at Boehringer Ingelheim. Stephan earned a PhD in Pharmacoepidemiology from the University of Florida, complementing their PharmD from Technische Universität Braunschweig. Earlier in their career, Stephan worked as a pharmacist at both Community Pharmacy and Sued Community Pharmacy.
This person is not in any teams
This person is not in any offices